Advertisements

Febridol (Acetaminophen)

Quick links to important sections

Febridol (Acetaminophen)

Advertisements

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Febridol (Acetaminophen)

Quick Facts

Property Description
Active ingredient Acetaminophen (Paracetamol)
Common Forms Tablets, Capsules, Oral Liquids, Suppositories
Pharmacological Class Analgesic (Pain Reliever) and Antipyretic (Fever Reducer)
General Purpose Relief of minor pain and reduction of fever
Origin Synthetic compound

What is Febridol (Acetaminophen) and What Class Does it Belong To?

Febridol is a brand-name medicine containing the active ingredient Acetaminophen, which is scientifically known internationally as Paracetamol. Febridol is typically available as an over-the-counter (OTC) medicine, making it readily accessible for managing common symptoms. It belongs to the Pharmacological Class of analgesics and antipyretics; it targets pain and fever centrally. Acetaminophen is a synthetic compound and is distinguished from non-steroidal anti-inflammatory drugs (NSAIDs) because it does not primarily reduce inflammation.


Composition, Origin, and Available Forms

The core identity of Febridol rests solely on its single active ingredient, Acetaminophen, which is present across all product forms under this brand. Febridol often includes forms tailored for specific groups, such as easily administered liquid suspensions. The medicine is prepared in several common Dosage Forms, including standard tablets and oral solutions, allowing for different Routes of Administration like oral or rectal use. Its availability in many forms supports its use as an analgesic. Recognizing the consistent active component across these various formulations is key to safe self-management.


The General Therapeutic Purpose of Febridol (Acetaminophen)

The general purpose of Febridol is to provide effective relief from minor aches, pains, and fever. This makes it a fundamental choice for managing symptoms associated with various conditions, such as headaches, the common cold, and general body aches. The ingredient is a core component in medical care for these symptoms. This role highlights the medicine's utility in easing discomfort during minor illnesses.

Regulatory References

  1. WHO Model List of Essential Medicines
Advertisements

What side effects are possible with Febridol (Acetaminophen)?

Possible Side Effects and Safety Information

This section describes officially documented adverse reactions and safety restrictions for acetaminophen, based strictly on government regulatory documents.

Serious Adverse Reactions

The most significant safety concerns documented for acetaminophen involve the risk of severe hepatotoxicity (liver damage), which can be fatal. This risk is especially heightened in cases of acute overdose or when maximum recommended doses are exceeded.

Regulatory documents also detail the risk of rare but serious skin reactions, including Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Acute Generalized Exanthematous Pustulosis (AGEP). These reactions are documented as very rare and require immediate clinical attention.

Adverse Reaction Categories

System-Organ Class Example Adverse Reactions Frequency Classification
Hepatobiliary Disorders Liver failure, hepatotoxicity Varies; severe form linked to dose
Skin & Subcutaneous Rash, serious skin reactions (SJS, TEN) Rare to Very Rare
Blood & Lymphatic System Blood disorders (e.g., thrombocytopenia) Rare

Population-Specific Safety Considerations

Certain patient groups are identified as having an increased risk of severe adverse effects, specifically liver damage. This includes patients with pre-existing liver impairment, severe renal impairment, or those with chronic alcoholism (consumption of three or more alcoholic drinks daily). Reduced doses or increased caution is required in these circumstances. Additionally, patients with conditions leading to reduced glutathione reserves (e.g., malnutrition) may be at higher risk.

Dose and Exposure Limitations

Regulatory warnings emphasize that the risk of severe liver damage is strongly associated with acute overdose (taking too much at once) and the cumulative use of multiple acetaminophen-containing products. This establishes a critical restriction on the maximum permissible daily intake to prevent life-threatening organ toxicity.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose of Febridol (Acetaminophen) carries an officially documented risk of severe hepatic injury and acute liver failure, which can be life-threatening if not managed immediately. Initial symptoms are often non-specific and may be delayed or absent for a significant period after ingestion. Documented early manifestations may include nausea, vomiting, sweating, abdominal pain, and loss of appetite. Later, signs such as jaundice may appear.

Required Emergency Actions

Regulatory authorities mandate that individuals must seek immediate medical attention or contact a Poison Control Center immediately following any suspected overdose. This action is required regardless of whether symptoms are currently present due to the potential for delayed, severe toxicity. Urgent medical help must be sought if more than the maximum dose is taken or if Febridol is combined with other medicines containing acetaminophen.

Official Management Procedures

The specific antidote, Acetylcysteine (N-acetylcysteine), is officially indicated to prevent or reduce liver damage and must be administered promptly. Overdose management requires continuous hospital monitoring and mandatory repeated blood testing to track acetaminophen concentration, liver enzymes (AST, ALT), and the International Normalized Ratio (INR). Regulatory information notes that individuals with pre-existing liver disease or chronic consumption of three or more alcoholic drinks daily are at increased risk of severe outcomes.

Advertisements

Therapeutic Uses of Febridol (Acetaminophen)

What Febridol (Acetaminophen) Treats: Main Uses and Benefits

Febridol is commonly used to help with symptomatic relief across multiple domains, supporting patients during difficult episodes marked by symptoms related to physical discomfort or systemic imbalance. It is generally applied across therapeutic contexts where short-term symptomatic assistance is needed, especially when symptoms create noticeable physiological strain. This medication is applied in situations involving certain distressing symptoms, contributing to the overall easing of the symptom load.

The medication helps address symptom clusters that may become intense or disruptive, including headache, muscular aches, backache, toothache, and the discomfort of menstrual cramps. It plays a role in managing fever that is often part of acute or disruptive episodes associated with illnesses such as the common cold or flu.

“This application assists with maintaining functional stability and contributes to improved comfort during periods of heightened symptoms.”

It may be considered relevant for use across conditions presenting with localized discomfort, such as mild osteoarthritis pain, and is often used during phases when symptoms become more noticeable, such as discomfort following vaccinations.


Quick Fact: Relief for Episodic Discomfort and Fever

Property Description
Primary Focus Symptomatic relief of mild to moderate pain and fever
Key Indications Headache, toothache, body aches, common cold/flu symptoms
Patient Benefit Supports general well-being by easing the overall symptom burden

Regulatory References

  1. NIH MedlinePlus overview of Acetaminophen
Advertisements

Eligibility and Restrictions for Use

Use of Febridol (Acetaminophen) is determined by specific regulatory criteria relating to a patient's physiological status and age. The medicine is contraindicated and must not be used by individuals with a documented hypersensitivity to acetaminophen or any of its excipients. An absolute non-eligibility rule applies to patients with severe hepatic impairment or severe active liver disease, as documented in official labeling.


Conditional and Restricted Use

The medicine is subject to conditional use in several populations. Patients with severe renal insufficiency (e.g., creatinine clearance le 30 mL/min) are eligible, but use is restricted and requires regulatory caution. Individuals with underlying conditions such as chronic alcoholism, malnutrition, or mild to moderate hepatic insufficiency are likewise placed under special precaution due to the potential for increased risk.


Age and Reproductive Eligibility

Standard eligibility is established for adults and adolescents. Pediatric use is restricted and defined by specific age and weight thresholds that vary by formulation. For pregnancy, use is permitted only when clinically needed and must be limited to the lowest effective dose for the shortest duration, as stated in official labeling. Use during lactation is generally considered acceptable at therapeutic doses.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Acetaminophen (Febridol) can interact with several substances, primarily by affecting its metabolism, absorption, or by producing enhanced pharmacodynamic effects with co-administered medicines. Patients should always consult official product labeling for a complete list of documented interactions.


Documented Pharmacological Interactions

Interacting Substance Category Interaction Effect Clinical Constraint
Coumarin Anticoagulants (e.g., Warfarin) Increased risk of bleeding due to potentiation of the anticoagulant effect, especially with high doses or prolonged use. Requires monitoring of INR and potential dose adjustment of the anticoagulant.
Hepatic Enzyme Inducers (e.g., Phenytoin, Carbamazepine) Increased formation of the toxic acetaminophen metabolite, elevating the risk of hepatotoxicity. Caution is required; risk is heightened in patients with compromised liver function or chronic alcohol use.
Alcohol Significantly increased risk of severe liver damage due to enhanced metabolic toxicity. Use is generally discouraged or requires strict limits for chronic heavy drinkers.
Gastrointestinal Motility Agents Agents like Metoclopramide can increase the rate of acetaminophen absorption, while Anticholinergics can slow it. May alter the onset of pain relief.
Cholestyramine Decreased absorption of acetaminophen. Dose separation is required (typically taking acetaminophen at least one hour before or several hours after Cholestyramine).

Note on Contraindications: Absolute drug-drug contraindications for single-ingredient acetaminophen are generally limited, but its use is restricted in patients with severe hepatic impairment or a history of hypersensitivity.

Advertisements

Mechanism of Action

Central Action on Prostaglandin Synthesis Pathways

Febridol (Acetaminophen) exerts its primary action within the Central Nervous System (CNS) by inhibiting the activity of Cyclooxygenase ( COX) enzymes, which are crucial for synthesizing Prostaglandin E2 ( PGE2). This central inhibition of PGE2 in the hypothalamus directly lowers the body's thermal set-point, resulting in a reduction of the hypothalamic temperature set-point.


Modulation of Endogenous Inhibitory Systems

The full mechanistic action involves the drug's active metabolite, AM404, which modulates the endocannabinoid and serotonergic descending inhibitory pathways. By influencing these intrinsic systems, the mechanism increases the activity of descending inhibitory pathways, thereby reducing ascending nociceptive input to the brain, leading to decreased central nociceptive signal output.


Limited Peripheral Anti-Inflammatory Activity

The drug's mechanism is characterized by a strong selectivity for the CNS and minimal activity on COX enzymes in peripheral tissues, particularly those with high peroxide levels found at injury sites. This allows the drug to avoid significantly interfering with peripheral prostaglandin production. Consequently, peripheral anti-inflammatory activity is not a primary mechanistic feature.

Advertisements

Dosage and Administration Information

How Febridol (Acetaminophen) is Used

The principles for using Febridol, which contains the active ingredient acetaminophen, relate to the route, frequency, and total intake. The medicine is administered via the oral, rectal, and intravenous (IV) infusion routes. Administration is typically on an as-needed basis (PRN) following fixed minimum time constraints between doses.

For immediate-release (IR) oral forms, a single dose may range from 325 mg up to 1000 mg, requiring a minimum interval of four to six hours between administrations. Extended-release (ER) formulations follow a distinct pattern, often involving 1300 mg taken every eight hours. A key administration instruction for ER forms is that the tablets must be swallowed whole and not crushed, chewed, or split to preserve the intended release profile.

The maximum total daily dose is a defining constraint, which must not exceed 4000 mg (4 g) from all acetaminophen-containing sources combined within a 24-hour period. This absolute limit may be reduced for specific populations; for example, patients with severe hepatic impairment may be restricted to a lower maximum daily intake, such as 3000 mg. Pediatric administration follows a weight-based regimen, typically 10 to 15 mg/kg per dose. Intravenous administration, reserved for clinical use, is delivered as a slow 15-minute infusion. The standard use pattern is characterized by short-term, intermittent application to manage acute episodes.

Advertisements

Recent Clinical Evidence

Febridol (Acetaminophen): Recent Clinical Evidence

Recent clinical research has focused on the efficacy and safety profile of acetaminophen in managing chronic pain conditions, particularly compared to its well-established role in acute pain and fever reduction.


Phase 3 Trials: Findings and Biological Activity

Clinical trials have been conducted to evaluate the use of acetaminophen in individuals with chronic pain, such as osteoarthritis (OA). Findings from systematic reviews suggest limited or inconsistent evidence for the long-term efficacy of acetaminophen as a single agent in continuous dosing regimens for chronic low back pain (CLBP) and OA.

  • Pain Metrics: While some studies report statistical differences in pain scores (e.g., VAS or WOMAC) favoring acetaminophen over placebo, the magnitude of these benefits has often been found to be not clinically significant.
  • Biological Activity: Research explores the drug's activity in the central nervous system (CNS), which may involve influencing pain signaling pathways and the endocannabinoid system. Studies have investigated the relationship between the drug's activity and inflammatory markers, noting its weak anti-inflammatory action compared to NSAIDs.

Safety and Patient-Reported Outcomes

Acetaminophen remains a preferred non-opioid analgesic due to its established favorable safety profile relative to other treatments, such as its lower risk of gastrointestinal bleeding or cardiovascular events at recommended doses.

  • Specific Populations: Acetaminophen is widely used in patient populations where NSAIDs are often avoided. The safety profile in individuals with stable liver disease has been assessed, though the maximum daily dose may require reduction.
  • Safety Concerns: Severe liver damage remains the primary safety risk, associated with acute overdose or chronic use exceeding recommended daily limits. Additionally, some population-based cohort studies in older adults have suggested a potential association between long-term, repeated acetaminophen use and an increased risk of gastrointestinal, cardiovascular (e.g., hypertension), and renal adverse events when compared to unexposed individuals.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Febridol (Acetaminophen) (FAQ)


Q: What are the general safety classifications for Febridol (Acetaminophen) use?

A: Febridol (Acetaminophen) is widely available as an Over-the-Counter ( OTC) medicine and is classified as an analgesic (pain reliever) and antipyretic (fever reducer). Official regulatory warnings emphasize the potential for severe liver damage if the medicine is misused or taken in amounts exceeding the recommended daily limit.

Q: Are there specific cold, flu, or allergy remedies that already contain acetaminophen?

A: Yes, acetaminophen is frequently included as an active ingredient in many combination medicines, particularly those designed to treat cold, flu, and allergy symptoms. Regulatory guidance stresses that consumers must check the 'Active Ingredient' section on all product labels to avoid accidentally combining them, which can lead to an overdose.

Q: What is the expected time for Febridol to start working to reduce a fever?

A: The fever-reducing effect requires the medicine to reach and influence the body's temperature regulation center in the brain. For this reason, the full reduction of fever may take slightly longer to become noticeable than the initial feeling of pain relief.

Q: Is there a difference in how quickly liquid and tablet forms of Febridol take to act?

A: Oral liquid forms and orally disintegrating tablets typically have a faster onset of action, often beginning to work within 20 minutes when taken on an empty stomach. Standard tablets usually require 30 to 45 minutes to start providing relief because they must first dissolve before absorption.

Q: What is the recommended guidance for using Febridol in infants and young children?

A: Official guidance defines pediatric dosage based strictly on the child's age and weight, following a milligram-per-kilogram regimen. Regulatory bodies indicate that the specific measuring device, such as the syringe or cup that comes with the product, should be used to ensure accurate administration.

Q: Does the safety profile of Febridol change for elderly patients?

A: Regulatory warnings emphasize that all adult patients, including the elderly, are directed to adhere to the maximum daily dose and carefully read product labels. The presence of coexisting health conditions may influence the risk profile, and this is a topic that can be reviewed with a healthcare professional.

Q: Is Febridol effective for relieving migraine headaches according to regulatory documents?

A: Acetaminophen used alone is officially indicated for general headaches. However, the FDA has recognized specific combination products that include acetaminophen along with aspirin and caffeine for use in treating acute migraine headaches.

Q: Why is it important to wait at least four hours between doses of Febridol?

A: The minimum time interval between doses (typically four hours for immediate-release forms) is specified to prevent the accumulation of the drug in the body. Adhering to this interval supports the maximum total daily dose limit, which minimizes the risk of severe liver damage.

Q: What is the current scientific discussion about Febridol use during pregnancy and neurodevelopmental conditions?

A: Regulatory authorities have noted an ongoing scientific discussion regarding studies that suggest a potential association between acetaminophen use during pregnancy and neurodevelopmental conditions in children. Official guidance maintains that use is permitted when clinically needed, and that the lowest effective amount for the shortest duration is consistent with the general recommendation for use during pregnancy.

Q: How can a person tell if an over-the-counter (OTC) product contains acetaminophen?

A: The OTC Drug Facts label is required to clearly list the medicine's active ingredients in a dedicated section. This 'Active Ingredient' listing is intended to be checked by consumers and will explicitly state 'Acetaminophen' if the substance is present in the product.

Q: What are the signs and symptoms associated with taking too much Febridol?

A: Initial, non-specific symptoms of an overdose may include feelings of general discomfort, abdominal pain, nausea, and vomiting. Official warnings emphasize that some people may experience no symptoms at all initially, and signs of severe liver damage may take several days to appear.

Q: How long does the pain relief effect of Febridol typically last in adults?

A: Official drug information indicates that the pain relief effect of immediate-release acetaminophen typically lasts for 4 to 6 hours. This duration is generally consistent across all approved routes of administration.

Q: For what maximum length of time is Febridol typically used for short-term symptoms without consulting a healthcare provider?

A: Regulatory directions on OTC labels specify that the product is intended for short-term use and that a healthcare provider should be consulted if pain persists for more than 10 days, or if a fever lasts for more than 3 days. These durations define the limits for consumer self-management of acute symptoms.

Q: What is the significance of the abbreviation 'APAP' sometimes found on medicine labels?

A: APAP is a recognized abbreviation for the active ingredient acetaminophen. However, many regulatory and health organizations express a preference for using the complete drug name 'acetaminophen' on labels and in documentation to help avoid medication errors and consumer confusion.

Q: What information is available on Febridol and its potential effect on male or female fertility?

A: Official regulatory guidance indicates that when the use of acetaminophen is clinically needed during pregnancy, the lowest effective dose for the shortest duration is consistent with the general recommendation. Research studies have investigated the drug’s potential effect on fetal reproductive development, and this area remains a topic of scientific investigation.

Q: What are the symptoms of metabolic acidosis, and how can Febridol relate to this condition?

A: Severe acetaminophen overdose can lead to serious complications such as metabolic acidosis or lactic acidosis, which is a significant clinical feature of severe drug toxicity. These conditions require intensive medical management to assess the patient's prognosis.

Q: Can Febridol be taken with or without food?

A: According to official product information, acetaminophen can generally be taken with or without food. Taking the medicine with a meal may slightly slow down the rate of absorption, which could delay the onset of pain relief.

Q: Do studies suggest a correlation between Febridol use and certain breathing problems?

A: The FDA requires an Allergy Alert on the product label, which warns that a severe allergic reaction to acetaminophen is possible. Symptoms of a severe allergic reaction may include breathing problems, such as wheezing or asthma.

Q: Why do some people experience nausea or vomiting after an overdose, and what does this indicate?

A: Nausea and vomiting are common initial symptoms of an acetaminophen overdose, though they are non-specific. Official warnings indicate that the presence of these symptoms is a signal to seek immediate medical attention, as prompt clinical attention is critical for preventing severe liver damage.

Q: Can Febridol be taken alongside other common painkillers that do not contain acetaminophen?

A: It is generally considered acceptable to take acetaminophen alongside non-steroidal anti-inflammatory drugs ( NSAIDs) like ibuprofen or naproxen, as the two types of medicines work by different mechanisms to treat pain. However, reviewing any concurrent use with a healthcare professional is a recommended safety measure.

Q: What is the purpose of the 'Drug Facts' label on an over-the-counter Febridol product?

A: The FDA requires the standardized OTC Drug Facts label to provide consumers with detailed usage and warning information in a consistent format. The purpose is to allow consumers to properly choose and use the product, thereby ensuring safe self-management.

Q: Why is the concentration of liquid Febridol products important to know for children?

A: Knowing the concentration is vital because different liquid products have different strengths ( e.g., 80 mg/mL vs. 160 mg/5 mL). Official warnings state that using the wrong concentration for a child’s weight can result in administering an incorrect dose, which may lead to accidental overdose and liver damage.

Advertisements

How should Febridol (Acetaminophen) be stored and disposed of?

The storage and disposal of Febridol (Acetaminophen) must comply with mandatory regulatory requirements to maintain product stability and ensure public safety.

Scope Item Official Regulatory Requirement
Storage Temperature Store at 20 to 25 C (68 to 77 F), which is Controlled Room Temperature, and do not freeze liquid forms.
Protection & Handling Keep the medicine out of the sight and reach of children and protect from moisture.
Container Rules Store the product in its original container and ensure it is kept tightly closed.
Disposal Instructions Drug take-back programs are the preferred disposal method for unused or expired medicine.
Environmental Rule Do not flush the product down the toilet or throw it into wastewater unless specifically indicated on the label.

These official statements define the required temperature and environmental protection to prevent degradation. Disposal must follow designated protocols, prioritizing take-back programs to prevent unauthorized use.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Febridol (Acetaminophen) found in:

A-Z Index: